Jena, Germany

Karl-Heinz Guhrs

This inventor holds 2 USPTO granted patents. Top assignees: Medac Gesellschaft Fur Klinische Spezialpraparate Mbh, Other. Active years: 1998-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karl-Heinz Guhrs. Retrieved from https://idiyas.com/inventor/karl-heinz-guhrs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Karl-Heinz Guhrs: Innovator in Staphylokinase Research

Introduction

Karl-Heinz Guhrs is a notable inventor based in Jena, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of recombinant staphylokinase polypeptides. With a total of 2 patents, his work has implications for medical applications and therapeutic advancements.

Latest Patents

One of his latest patents is focused on the expression of signal-peptide-free staphylokinases. This invention relates to recombinant staphylokinase polypeptides that exhibit a plasminogen activator effect. The polypeptides are produced by expressing DNA sequences that are devoid of signal-peptide-coding regions. This innovative approach enhances the efficiency of staphylokinase production for potential therapeutic uses.

Career Highlights

Throughout his career, Karl-Heinz Guhrs has worked with Medac Gesellschaft für Klinische Spezialpräparate mbH, a company known for its clinical specialty preparations. His expertise in biochemistry and molecular biology has positioned him as a key figure in his field.

Collaborations

Karl-Heinz has collaborated with notable colleagues, including Bernhard Schlott and Sybille Albrecht. Their combined efforts have contributed to advancements in the understanding and application of staphylokinases.

Conclusion

Karl-Heinz Guhrs is a distinguished inventor whose work in staphylokinase research has the potential to impact medical science significantly. His innovative patents and collaborations reflect his commitment to advancing biochemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…